Our Team

Our Team

A world-class team dedicated to transforming the treatment of cancer

We have assembled the best and brightest team of scientists and industry professionals with a strong passion for science and collaboration. Our leadership team, our world-class scientific advisors, and our engaged directors are working together to advance our next-generation immunotherapies and to give patients hope in their fight against cancer.

Management

 

Daniel Lynch

Daniel Lynch

Executive Chairman, Interim CEO
Jeff Goater

Jeff Goater

Chief Business Officer
Scott Chappel, PhD

Scott Chappel, PhD

Chief Technology Officer
Jessica Fees

Jessica Fees

Head of Finance
Nicholas Buffinger, PhD, JD

Nicholas Buffinger, PhD, JD

Vice President, Business Operations
Pamela Holland, PhD

Pamela Holland, PhD

Vice President, Cancer Biology
Lisa McGrath,

Lisa McGrath,

Vice President, Human Resources
Vito Palombella, PhD

Vito Palombella, PhD

Chief Scientific Officer
Robert Ross, MD

Robert Ross, MD

Chief Medical Officer

Board of Directors

Daniel Lynch

Daniel Lynch

Executive Chairman, Interim CEO
Detlev Biniszkiewicz, PhD

Detlev Biniszkiewicz, PhD

Director
David Grayzel, MD

David Grayzel, MD

Director
Armen Shanafelt, PhD

Armen Shanafelt, PhD

Director
Robert Weisskoff, PhD

Robert Weisskoff, PhD

Observer
Chris Klee

Chris Klee

Observer
Janis Naeve, PhD

Janis Naeve, PhD

Observer

Scientific Advisory Board